Compare RMD & RKLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RMD | RKLB |
|---|---|---|
| Founded | 1989 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Aerospace |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.4B | 42.8B |
| IPO Year | 1995 | N/A |
| Metric | RMD | RKLB |
|---|---|---|
| Price | $267.01 | $65.37 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 14 |
| Target Price | ★ $293.70 | $63.08 |
| AVG Volume (30 Days) | 1.1M | ★ 24.3M |
| Earning Date | 01-29-2026 | 02-26-2026 |
| Dividend Yield | ★ 0.91% | N/A |
| EPS Growth | ★ 19.37 | N/A |
| EPS | ★ 10.11 | N/A |
| Revenue | ★ $5,398,119,000.00 | $554,535,000.00 |
| Revenue This Year | $9.88 | $40.33 |
| Revenue Next Year | $7.37 | $50.34 |
| P/E Ratio | $26.01 | ★ N/A |
| Revenue Growth | 9.57 | ★ 52.42 |
| 52 Week Low | $199.92 | $14.71 |
| 52 Week High | $293.81 | $99.58 |
| Indicator | RMD | RKLB |
|---|---|---|
| Relative Strength Index (RSI) | 64.46 | 38.64 |
| Support Level | $250.54 | $73.88 |
| Resistance Level | $258.45 | $81.35 |
| Average True Range (ATR) | 6.95 | 7.68 |
| MACD | 0.68 | -3.21 |
| Stochastic Oscillator | 94.96 | 1.37 |
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Rocket Lab Corp is engaged in space, building rockets, and spacecraft. It provides end-to-end mission services that provide frequent and reliable access to space for civil, defense, and commercial markets. It designs and manufactures the Electron and Neutron launch vehicles and Photon satellite platform. Rocket Lab's Electron launch vehicle has delivered multiple satellites to orbit for private and public sector organizations, enabling operations in national security, scientific research, space debris mitigation, Earth observation, climate monitoring, and communications. The business operates in two segments Launch Services and Space Systems. Geographically it serves Japan, Germany, and rest of the world and earns key revenue from the United States.